Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes

被引:115
作者
Oddoze, C
Morange, S
Portugal, H
Berland, Y
Dussol, B
机构
[1] Hop Conception, Serv Nephrol, F-13385 Marseille 05, France
[2] Hop St Marguerite, Cent Lab, Marseille, France
[3] Hop St Marguerite, Ctr Invest Clin, Marseille, France
关键词
cystatin C; beta(2)-microglobulin; creatinine; glomerular filtration rate (GFR); diabetes;
D O I
10.1053/ajkd.2001.26096
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This study evaluated serum cystatin C as a potential new marker of glomerular filtration rate (GFR) in 49 patients who had steady-state diabetes with early renal impairment. We determined the correlation between GFR measured by chromium 51-labeled EDTA and levels of serum cystatin C, serum creatinine, serum beta (2)-microglobulin, endogenous creatinine clearance, and Cockcroft formula. Sensitivity and specificity for the diagnosis of renal failure, defined as a GFR less than either 80 or 60 mL/min/1.73 m(2), were calculated by receiver operating characteristic (ROC) curves for creatinine, cystatin C, and beta (2)-microglobulin. Finally, we compared mean values of these three serum parameters in patients grouped according to GFR using the two definitions of renal failure. Correlation coefficients with GFR were -0.77 for serum creatinine level, -0.65 for serum cystatin C level, -0.71 for serum beta (2)-microglobulin level, +0.56 for endogenous creatinine clearance, and +0.69 for Cockcroft formula (all P < 0.001). With a cutoff value of 60 mL/min/1.73 m(2), areas under the ROC curve were 0.972 for beta(2)-microglobulin, 0.925 for cystatin C, and 0.916 for creatinine levels. With a cutoff value of 80 mL/min/1.73 m(2), these were 0.838 for beta (2)-microglobulin, 0.780 for cystatin C, and 0.905 for creatinine levels (P = not significant between parameters). These results were not altered after the exclusion of patients (n = 8) with a serum creatinine level greater than 1.41 mg/dL. When patients were classified into three groups according to GFR (group 1, >80 mL/min/1.73 m(2); group 2,60 to 80 mL/min/1.73 m(2); group 3, <60 mL/min/1.73 m(2)), mean values of serum parameters in the three groups were statistically different (P < 0.0001) except between groups 1 and 2 for cystatin C and beta (2)-microglobulin. With patients classified into two groups (GFR > or < 80 mL/min/1.73 m(2)), mean values for each parameter were statistically different (P < 0.001). Sensitivity, specificity, and positive and negative predictive values for serum creatinine and serum cystatin C levels were very close for both definitions of renal failure. Serum cystatin C Is not better than serum creatinine or serum beta (2)-microglobulin levels for estimating GFR in patients with steady-state diabetes using ROC curves or other validation tests. (C) 2001 by the National Kidney Foundation, Inc.
引用
收藏
页码:310 / 316
页数:7
相关论文
共 25 条
[11]   Cystatin C: Efficacy as screening test for reduced glomerular filtration rate [J].
Herget-Rosenthal, S ;
Trabold, S ;
Pietruck, F ;
Holtmann, M ;
Philipp, T ;
Kribben, A .
AMERICAN JOURNAL OF NEPHROLOGY, 2000, 20 (02) :97-102
[12]  
KAMPMANN J, 1974, ACTA MED SCAND, V196, P517
[13]  
KNULMAN JT, 1988, CLIN CHEM, V34, P135
[14]  
LEVEY AS, 1988, ANNU REV MED, V39, P465, DOI 10.1146/annurev.med.39.1.465
[15]   Validity of rapid estimation of glomerular filtration rate in type 2 diabetic patients with normal renal function [J].
Nielsen, S ;
Rehling, M ;
Schmitz, A ;
Mogensen, CE .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (03) :615-619
[16]   Reference intervals for the glomerular filtration rate and cell-proliferation markers: serum cystatin C and serum beta(2)microglobulin/cystatin C-ratio [J].
Norlund, L ;
Fex, G ;
Lanke, J ;
VonSchenck, H ;
Nilsson, JE ;
Leksell, H ;
Grubb, A .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1997, 57 (06) :463-470
[17]   Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C [J].
Risch, L ;
Blumberg, A ;
Huber, A .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (08) :1991-1996
[18]   Determination of serum cystatin C in patients with essential hypertension [J].
Seco, ML ;
Rus, A ;
Sierra, M ;
Caballero, M ;
Borque, L .
NEPHRON, 1999, 81 (04) :446-447
[19]   LIMITATIONS OF CREATININE AS A FILTRATION MARKER IN GLOMERULOPATHIC PATIENTS [J].
SHEMESH, O ;
GOLBETZ, H ;
KRISS, JP ;
MYERS, BD .
KIDNEY INTERNATIONAL, 1985, 28 (05) :830-838
[20]  
SPENCER K, 1986, ANN CLIN BIOCHEM, V23, P1